Fuhri Snethlage, C. M. (2024). Type 1 diabetes: A better understanding of the gut-immune axis. [Thesis, fully internal, Universiteit van Amsterdam].
Warmbrunn, M. V. (2024). A kick in the guts: Insulin resistance, gut microbiota and cardiometabolic diseases. [Thesis, fully internal, Universiteit van Amsterdam].
Majait, S. (2024). Bile and bugs: Unraveling the postprandial response of bile acids and gut microbiota in (inherited) metabolic diseases. [Thesis, fully internal, Universiteit van Amsterdam].
Balvers, M. (2024). The human genome and microbiome in cardiometabolic disease: Exploration through sequence-based technologies. [Thesis, fully internal, Universiteit van Amsterdam].
Mens, M. A. (2023). Innovative CT in diabetic foot disease: A multidisciplinary approach. [Thesis, fully internal, Universiteit van Amsterdam].
Habibe, J. J. (2023). The emerging role of FHL2 in metabolism. [Thesis, fully internal, Universiteit van Amsterdam].
Houttu, V. (2023). Dissecting the interplay of exercise, gut microbiota and NAFLD. [Thesis, fully internal, Universiteit van Amsterdam].
Mak, A. L. (2023). Metabolic dysfunction-associated steatotic liver disease: A wide-angled perspective on a multifaceted problem. [Thesis, fully internal, Universiteit van Amsterdam].
Wijdeveld, M. (2023). Gut-brain interactions affecting metabolic health and central appetite regulation in diabetes, obesity and aging. [Thesis, fully internal, Universiteit van Amsterdam].
Meiring, S. (2023). Clinical and mechanistic studies of duodenal mucosal resurfacing for type 2 diabetes. [Thesis, fully internal, Universiteit van Amsterdam].
